Product Information
DABIGATRAN ETEXILATE 75 MG CAP is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.8983 per EA under NDC 31722062160. Its NADAC has been published 171 times since Mar 22, 2023.
Strength
75 mg/1
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722062160
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
DABIGATRAN ETEXILATE MESYLATEApproval Type
Generic (ANDA)
FDA Application
ANDA207961On Market Since
5/6/2020
Pharmacological Classes
Price Statistics
The NADAC for DABIGATRAN ETEXILATE 75 MG CAP has been published 171 times since Mar 22, 2023, and over the history we have for it it has declined 85.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.8983 per EA |
|---|---|
| All-time high | $6.3586 (Apr 10, 2024) |
| All-time low | $0.8478 (Apr 22, 2026) |
| 52-week high | $1.4699 |
| 52-week low | $0.8478 |
| Median price | $2.0801 |
| Average price | $3.1506 |
| Largest weekly change | -58.2% (Apr 17, 2024) |
| Weeks tracked | 171 |
| Tracking since | Mar 22, 2023 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of DABIGATRAN ETEXILATE 75 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for DABIGATRAN ETEXILATE 75 MG CAP, manufactured by Camber Pharmaceuticals Inc., is $0.8983 per EA (NDC 31722062160), effective Jun 24, 2026.
How has the price of DABIGATRAN ETEXILATE 75 MG CAP changed over time?
Over the history we have for it, the NADAC for DABIGATRAN ETEXILATE 75 MG CAP has declined 85.3%. It has been tracked across 171 weekly CMS publications since Mar 22, 2023.
What are the highest and lowest recorded NADAC prices for DABIGATRAN ETEXILATE 75 MG CAP?
Since Mar 22, 2023, the NADAC for DABIGATRAN ETEXILATE 75 MG CAP has ranged from a low of $0.8478 (Apr 22, 2026) to a high of $6.3586 (Apr 10, 2024), with a median of $2.0801 per EA.
Are there cheaper alternatives to DABIGATRAN ETEXILATE 75 MG CAP?
5 NADAC-published products share the same active ingredient, strength, and dosage form as DABIGATRAN ETEXILATE 75 MG CAP, but none are currently priced below it.
Who manufactures DABIGATRAN ETEXILATE 75 MG CAP?
DABIGATRAN ETEXILATE 75 MG CAP (NDC 31722062160) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification